Literature DB >> 12477835

Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus.

Diane M LoPiccolo1, Marielle C Gold, Daniel G Kavanagh, Markus Wagner, Ulrich H Koszinowski, Ann B Hill.   

Abstract

Macrophages play an important role in murine cytomegalovirus (MCMV) infection in vivo, both in disseminating infection and in harboring latent virus. MCMV encodes three immune evasion genes (m4, m6, and m152) that interfere with the ability of cytotoxic T cells (CTL) to detect virus-infected fibroblasts, but the efficacy of immune evasion in macrophages has been controversial. Here we show that MCMV immune evasion genes function in H-2(b) primary bone marrow macrophages (BMMphi) in the same way that they do in fibroblasts. Metabolic labeling experiments showed that class I is retained in the endoplasmic reticulum by MCMV infection and associates with m4/gp34 to a similar extent in fibroblasts and BMMphi. We tested a series of K(b)- and D(b)-restricted CTL clones specific for MCMV early genes against a panel of MCMV wild-type virus and mutants lacking m152, m4, or m6. MCMV immune evasion genes effectively inhibited antigen presentation. m152 appeared sufficient to abolish D(b)-restricted presentation in infected macrophages, as has been previously observed in infected fibroblasts. However, for inhibition of recognition of infected macrophages by K(b)-restricted CTL, m4, m6, and m152 were all required. The contribution of m4 to inhibition of recognition appeared much more important in macrophages than in fibroblasts. Thus, MCMV immune evasion genes function effectively in primary macrophages to prevent CTL recognition of early antigens and show the same pattern of major histocompatibility complex class I allele discrimination as is seen in fibroblasts. Furthermore, for inhibition of K(b)-restricted presentation, a strong synergistic effect was noted among m152, m4, and m6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477835      PMCID: PMC140608          DOI: 10.1128/jvi.77.1.301-308.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.

Authors:  M Wagner; S Jonjic; U H Koszinowski; M Messerle
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus.

Authors:  H Hengel; U Reusch; G Geginat; R Holtappels; T Ruppert; E Hellebrand; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Relationship between the production of murine cytomegalovirus and interferon in macrophages.

Authors:  T Yamaguchi; Y Shinagawa; R B Pollard
Journal:  J Gen Virol       Date:  1988-12       Impact factor: 3.891

4.  Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency.

Authors:  A R Brautigam; F J Dutko; L B Olding; M B Oldstone
Journal:  J Gen Virol       Date:  1979-08       Impact factor: 3.891

5.  Studies of latent cytomegalovirus infection: the macrophage as a virus-harboring cell.

Authors:  K Hayashi; K Saze; Y Uchida
Journal:  Microbiol Immunol       Date:  1985       Impact factor: 1.955

6.  The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.

Authors:  Marielle C Gold; Michael W Munks; Markus Wagner; Ulrich H Koszinowski; Ann B Hill; Steven P Fling
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

7.  Lethal infection with murine cytomegalovirus after early viral replication in the spleen.

Authors:  D A Katzenstein; G S Yu; M C Jordan
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

8.  An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T lymphocytes.

Authors:  A E Campbell; J S Slater; V J Cavanaugh; R M Stenberg
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo.

Authors:  A Krmpotic; M Messerle; I Crnkovic-Mertens; B Polic; S Jonjic; U H Koszinowski
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

10.  Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus.

Authors:  Markus Wagner; Anja Gutermann; Jürgen Podlech; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  13 in total

1.  Cytomegalovirus encodes a positive regulator of antigen presentation.

Authors:  Rafaela Holtappels; Dorothea Gillert-Marien; Doris Thomas; Jürgen Podlech; Petra Deegen; Sylvia Herter; Silke A Oehrlein-Karpi; Dennis Strand; Markus Wagner; Matthias J Reddehase
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Cellular and molecular requirements for association of the murine cytomegalovirus protein m4/gp34 with major histocompatibility complex class I molecules.

Authors:  Xiuju Lu; Daniel G Kavanagh; Ann B Hill
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.

Authors:  Christopher S Morello; Ming Ye; Stephanie Hung; Laura A Kelley; Deborah H Spector
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors.

Authors:  Joseph C Sun; Lewis L Lanier
Journal:  Viruses       Date:  2009       Impact factor: 5.048

5.  Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.

Authors:  Ming Ye; Christopher S Morello; Deborah H Spector
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40.

Authors:  Amelia K Pinto; Amanda M Jamieson; David H Raulet; Ann B Hill
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 7.  MHC class I immune evasion in MCMV infection.

Authors:  Carmen M Doom; Ann B Hill
Journal:  Med Microbiol Immunol       Date:  2008-03-11       Impact factor: 3.402

8.  Murine cytomegalovirus paralyzes macrophages by blocking IFN gamma-induced promoter assembly.

Authors:  Daniel L Popkin; Mark A Watson; Elizabeth Karaskov; Gavin P Dunn; Rod Bremner; Herbert W Virgin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

9.  Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.

Authors:  Suresh B Boppana; William J Britt
Journal:  Methods Mol Biol       Date:  2021

10.  NK cell receptor/H2-Dk-dependent host resistance to viral infection is quantitatively modulated by H2q inhibitory signals.

Authors:  Nassima Fodil-Cornu; J Concepción Loredo-Osti; Silvia M Vidal
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.